Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) Uniunea Europeană - română - EMA (European Medicines Agency)

lenalidomide krka (previously lenalidomide krka d.d. novo mesto)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imunosupresoare - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 și 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 și 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

PROTOXID DE AZOT MESSER 100% România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

protoxid de azot messer 100%

messer industriegase gmbh - germania - protoxid de azot - gaz medicinal, lichefiat - 100% - anestezice generale alte anestezice generale

MONOXID DE AZOT MESSER 800 PPM (V/V) România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

monoxid de azot messer 800 ppm (v/v)

messer austria gmbh - austria - ) emite o cerere oxidum - gaz medicinal comprimat - 800ppm(v/v) - alte med. pentru tratamentul ap. respirator alte med. pt. aparatul respirator

OXIGEN LINDE 100% România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

oxigen linde 100%

linde gas a.s. - republica ceha - oxigenum - gaz medicinal criogenic - 100% - alte preparate terapeutice gaze medicinale

SERYNOX 50% / 50% România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

serynox 50% / 50%

messer france - franta - protoxid de azot + oxigen - gaz medicinal comprimat - 50%/50% - anestezice generale alte anestezice generale

MAASOL 1,75 mg/flacon România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

maasol 1,75 mg/flacon

gipharma s.r.l. - italia - macroagregate de albuȘuri de ou umana - kit pt. prep. susp.inj, radiofarmaceutic - 1,75 mg/flacon - sistem respirator particule cu technetium pt. injectare

ENTONOX 50%/50% România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

entonox 50%/50%

aga gas ab - suedia - protoxid de azot + oxigen - gaz medicinal, comprimat - 50%/50% - anestezice generale alte anestezice generale

OXIGEN MEDICINAL COMPRIMAT România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

oxigen medicinal comprimat

siad romania s.r.l. - romania - oxigenum - gaz medicinal, comprimat - alte preparate terapeutice gaze medicinale

OXIGEN MEDICINAL LICHEFIAT România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

oxigen medicinal lichefiat

siad romania s.r.l. - romania - oxigenum - gaz medicinal, lichefiat - alte preparate terapeutice gaze medicinale